Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Teva Pharmaceuticals USA

Teva Pharmaceuticals USA Recalls

All product recalls associated with Teva Pharmaceuticals USA.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1141–1160 of 4747 recalls

Idarubicin Hydrochloride (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Octreotide Acetate Injection (Teva) – Sterility Issue (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Cyclobenzaprine Hydrochloride (Teva) – Microbial Count Issue (2021)

CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Class II

1...56 575859 60...238

Page 58 of 238Next

Moderate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Leucovorin Calcium (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Ethosuximide Oral Solution (PAI Holdings) – CGMP Violation (2021)

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Class IIModerate

FDAJul 29, 2021Nationwide• PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Norepinephrine Bitartrate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Venlafaxine Tablets (Sun Pharma) – Foreign Tablets (2021)

Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg

Class IIModerate

FDAJul 29, 2021TN• SUN PHARMACEUTICAL INDUSTRIES INC

Octreotide Acetate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Cimetidine Hydrochloride (PAI Holdings) – CGMP Violation (2021)

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Class IIModerate

FDAJul 29, 2021Nationwide• PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Haloperidol Decanoate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Leucovorin Calcium Injection (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Amikacin Sulfate Injection (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Octreotide Acetate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Leucovorin Calcium (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Cyclobenzaprine Hydrochloride (Teva) – Microbial Count Issue (2021)

CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA